Reliance, Inc.
RS
$427.15
+1.44%
Reliance, Inc. is North America's largest metals service center company, distributing a full line of over 100,000 metal products — including carbon steel, aluminum, stainless steel, alloy, brass, copper, and titanium — to more than 125,000 customers across consumer products, general manufacturing, non-residential construction, transportation, aerospace, energy, electronics, and semiconductor fabrication, while also operating toll processing services for the automotive industry. Its scale, breadth of inventory, and decentralized operating model distinguish it as the dominant consolidator and value-added distributor in a highly fragmented metals distribution industry, giving it purchasing leverage and pricing power that smaller regional service centers cannot match. The current investor narrative centers on a powerful cyclical recovery: Q3 2026 revenue surged 42.8% year-over-year to $5.21 billion with EPS of $7.90, driven by improved steel pricing (echoed by Nucor's upbeat Q3 guidance) and volume growth, while the stock has rallied roughly 52% over the past year. Debate now hinges on whether this earnings inflection is sustainable into 2027 or whether margin normalization and soft non-residential construction demand will cap the upcycle, a tension reflected in the stock's recent pullback from its highs and the cautious 'hold' consensus among analysts.…
RS
Reliance, Inc.
$427.15
Related headlines
Investment Opinion: Should I buy RS Today?
Rating: Hold. Reliance is a high-quality, conservatively financed cyclical distributor whose recovery is real but already reflected in the price — with the stock at $417.00 against an average analyst target of $430.89 (+3.3% upside) and a consensus of 6 Hold, 2 Buy, and 1 Sell (mean rating 2.67), the risk/reward for new capital is balanced at best. The core thesis is that Q3 2026's $7.90 EPS and 10.59% operating margin represent a strong but potentially near-peak earnings base, and investors are being asked to pay a mid-cycle 20.53x trailing / 16.22x forward multiple for it.
Supporting evidence is genuinely strong on the operating side: revenue grew 42.8% year-over-year to $5.213 billion, EPS more than doubled from $3.59, operating margin expanded roughly 145 basis points sequentially to 10.59%, and the balance sheet carries just 0.278 debt-to-equity with a 4.88 current ratio and ~30x interest coverage. Valuation is not stretched on sales — the 1.06x PS ratio sits near the low end of its multi-year range and the 13.01x EV/EBITDA is only a modest premium to the 8-11x typical for steel distributors — but the 3.2% free cash flow yield ($491.9 million TTM FCF on a ~$15.2 billion market cap) and the $291.8 million Q3 working capital absorption show earnings are not converting cleanly to cash. The stock's 51.85% one-year gain versus SPY's 9.59% (+42.26 relative strength) confirms the market has already rewarded the recovery.
Three risks could invalidate the thesis: a steel price rollover that makes the $16.91 forward EPS estimate 20-30% too high, a break below the $380.31 August swing low that opens the door to the $340-$360 zone (-14% to -18%), and margin normalization back toward the 5.17% TTM net margin from Q3's 7.73%. This Hold would upgrade to Buy on a pullback toward the $380 support with margins intact, or if forward EPS estimates prove conservative and the multiple compresses below 15x; it would downgrade to Sell on a decisive break below $380 or evidence that Q4 gross margin falls below the 26.6% low end of the recent band. Net verdict: fairly valued relative to history and modestly premium to peers — a quality cyclical at a fair price, not a bargain.
Sign up to view all
RS 12-Month Price Forecast
Reliance presents a fairly valued quality cyclical: the operating recovery is genuine and broad-based, but the 51.85% one-year rally, the +3.3% implied upside to the average target, and the 6-of-9 Hold consensus all indicate the market has already priced the upcycle. The 16.22x forward multiple is reasonable if the $16.91 EPS estimate holds, but that estimate assumes Q3's 10.59% operating margin is a new baseline rather than a cyclical peak — the single variable that most determines the outcome. With a 0.953 beta and a fortress balance sheet, downside is cushioned, but the tight analyst range and absence of rating changes leave asymmetric risk skewed modestly lower if Q4 disappoints. I would upgrade to bullish on a pullback toward the $380 support with margins intact or on evidence that steel pricing is extending into 2027; I would downgrade to bearish on a decisive break below $380 or a Q4 gross margin falling below 26.6%.
Wall Street consensus
Nine analysts cover Reliance with a consensus recommendation of 'hold' (mean rating 2.67 on a 1-5 scale where higher is more bearish), distributed as 2 Buy, 6 Hold, and 1 Sell — a distinctly cautious stance for a stock up 52% in a year. The average target price of $430.89 implies just +3.3% upside from the current $417.00, and notably even the low target of $420.00 sits above the current price, meaning the entire analyst range is above market — a configuration that suggests targets may be lagging the stock's run rather than leading it. The consensus leans neutral-to-cautious, consistent with the view that the cyclical recovery is largely priced in.
The full target range of $420.00 to $446.00 is unusually tight — a spread of only 6.2% between low and high — signaling strong analyst conviction about fair value but also limited imagination about upside catalysts; the high target of $446 implies roughly 7% upside and would require either further steel price appreciation or multiple expansion toward the 52-week high of $454.93, while the low target of $420 essentially prices in a plateau where earnings hold but the cycle stalls. Institutional ratings show a pattern of reaffirmations rather than changes — JP Morgan (Neutral, reaffirmed October 28), Barclays (Equal Weight, October 26), KeyBanc (Overweight, October 26), and Wells Fargo (Equal Weight, October 22) — with no upgrades or downgrades in the recent tape, indicating a wait-and-see posture into year-end. The tight spread and absence of rating changes imply the market has efficiently priced the recovery, and the stock's recent pullback from $448 to $417 has brought it close to consensus fair value, leaving asymmetric risk skewed to the downside if Q4 results disappoint.
Bulls vs Bears: RS Investment Factors
The bull case rests on a genuine, broad-based cyclical recovery: 42.8% revenue growth, EPS more than doubling to $7.90, operating margin expansion of 145 basis points sequentially, and a fortress balance sheet with 0.28 debt-to-equity. The bear case is equally grounded: analysts see only 3.3% upside with a 'hold' consensus, free cash flow yield is a thin 3.2% due to working capital absorption, and roughly 60% of revenue is levered to carbon steel pricing that may be near a cyclical peak. On balance, the bear evidence currently carries slightly more weight for new money at $417, because the stock has already delivered 51.85% in a year and the entire analyst target range sits barely above the current price — the recovery is priced. The single most important tension is whether Q3's 10.59% operating margin is a durable new baseline or a cyclical peak; if margins hold through 2027 the forward PE of 16.2x is cheap, but if steel pricing rolls over, the market is paying a mid-cycle multiple on peak earnings.
Bullish
- Explosive earnings inflection underway: Q3 2026 EPS of $7.90 more than doubled year-over-year from $3.59, and revenue surged 42.8% to $5.213 billion from $3.651 billion. The sequential climb from Q4 2025's $2.24 EPS trough to $7.90 in three quarters demonstrates powerful operating leverage in the distribution model.
- Operating margin expansion from SG&A leverage: Operating margin climbed to 10.59% in Q3 from 9.54% in Q2 and 9.14% in Q1, a roughly 145 basis point sequential gain, while gross margin held in the 26.6%-27.9% band. SG&A of $901.8 million against $5.213 billion revenue shows fixed costs being absorbed by volume and pricing gains.
- Fortress balance sheet with minimal leverage: Debt-to-equity of just 0.278, a current ratio of 4.88, and interest coverage near 30x (operating income of $552.1 million versus $18.4 million interest expense) give Reliance ample capacity to fund working capital, buybacks ($44.7 million in Q3), and dividends ($63.8 million) without external financing.
- Massive relative strength versus the market: The stock is up 51.85% over the past year versus SPY's 9.59%, a +42.26 relative strength spread, and has outperformed by 10.23 points over the past month while SPY fell 4.99%. This defensive leadership in a declining tape signals genuine institutional accumulation.
Bearish
- Analyst consensus offers almost no upside: The average target of $430.89 implies just +3.3% upside from $417.00, and the entire $420-$446 range is unusually tight at a 6.2% spread. With 6 of 9 analysts at Hold and 1 at Sell, the professional community sees the recovery as largely priced in.
- Thin free cash flow yield despite earnings surge: TTM free cash flow of $491.9 million against a market cap of roughly $15.2 billion yields only about 3.2%, and Q3 working capital absorbed $291.8 million including a $265.3 million receivables build. Earnings quality is diluted by cash tied up in the revenue ramp.
- Carbon steel concentration ties results to pricing: Carbon steel revenue of $3.119 billion represents roughly 60% of the $5.213 billion quarterly total, making results heavily levered to steel pricing that Nucor's guidance suggests is cyclical. A rollover in steel prices would hit both volume and margin simultaneously.
- Sharp momentum deceleration and supply overhead: The stock is down 1.62% over three months despite being up 5.24% in the past month, and it suffered an 11% three-session drop in August (from $428.02 to $380.31) plus a -5.6% two-day reversal in early November. The $428-$448 zone has repeatedly rejected price, forming a formidable supply barrier.
RS Technical Analysis
Reliance is in a sustained, powerful uptrend, with the stock up 51.85% over the past year and 40.96% year-to-date, dramatically outperforming the S&P 500's 9.59% and 7.83% respective gains. At the current price of $417.00, the stock sits at approximately 80.2% of its 52-week range (low of $263.12 to high of $454.93), positioning it in the upper portion of its range but not at the extreme highs — a zone that typically signals healthy momentum rather than overextension, especially given the recent consolidation from the $448 peak reached on November 2. The relative strength readings confirm this leadership, with a 1-year relative strength of +42.26 versus SPY and a YTD relative strength of +33.13, indicating persistent and substantial alpha generation.
Short-term momentum is positive but decelerating: the stock is up 5.24% over the past month (versus SPY's -4.99%, a +10.23 relative strength spread) and up 12.92% over six months, yet it has slipped -1.62% over three months — a divergence that reveals a sharp August drawdown (from $428.02 on August 17 to $380.31 on August 20, a roughly 11% drop in three sessions) followed by a methodical recovery. The most recent action shows a notable one-day reversal, with the stock falling from $441.95 on November 4 to $414.04 on November 5 before stabilizing at $417.00, a -5.6% two-day swing that suggests profit-taking near the highs rather than a trend breakdown. The 1-month outperformance against a declining market (+10.23 relative strength) is a bullish signal of defensive leadership, but the negative 3-month print warns that the August high near $428-$448 remains a formidable supply zone.
Key technical levels are well defined: immediate resistance sits at the 52-week high of $454.93 (roughly 9.1% above the current price), with secondary resistance at the November 2 close of $448.08, while support rests at the August swing low of $380.31 (about 8.8% below current levels) and the 52-week low of $263.12 as the ultimate floor. A breakout above $454.93 would confirm the resumption of the primary uptrend and likely trigger momentum-driven buying, whereas a breakdown below $380 would signal a failed breakout and open the door to a deeper mean-reversion move. With a beta of 0.953, Reliance is slightly less volatile than the broader market — a defensive characteristic for a cyclical steel distributor — meaning position sizing can be somewhat more aggressive than for high-beta cyclicals, though the -19.37% max drawdown over the period underscores that sector-specific shocks (like the August air-pocket) can still produce meaningful capital risk.
Beta
—
—
Max Drawdown
-19.4%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
+57.1%
Cumulative gain past year
| Period | RS Return | S&P 500 |
|---|---|---|
| 1m | +6.1% | -3.7% |
| 3m | +0.0% | -2.9% |
| 6m | +16.1% | +0.2% |
| 1y | +57.1% | +10.1% |
| ytd | +44.4% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RS Fundamental Analysis
Reliance's revenue trajectory has inflected sharply upward: Q3 2026 revenue of $5.213 billion grew 42.78% year-over-year versus Q3 2025's $3.651 billion, and rose sequentially from $4.630 billion in Q2 and $4.026 billion in Q1 2026, marking three consecutive quarters of accelerating growth. The segment mix shows carbon steel as the dominant driver at $3.119 billion, followed by aluminum at $861.7 million, stainless steel at $634.9 million, and other/eliminations at $91 million — meaning the recovery is broad-based but heavily levered to carbon steel pricing and volume, consistent with the industry-wide pricing recovery signaled by Nucor's guidance. This acceleration from a trough quarter (Q4 2025 revenue of $3.499 billion, EPS of $2.24) to Q3 2026 EPS of $7.90 represents a dramatic cyclical earnings snap-back that validates the bull case for operating leverage in a distribution model.
Profitability has expanded materially: Q3 2026 net income reached $402.9 million (net margin 7.73%) on gross profit of $1.454 billion, a gross margin of 27.89% that improved from 26.59% in Q2 and 27.39% in Q1, while operating margin climbed to 10.59% from 9.54% and 9.14% in the prior two quarters. The margin progression is the key tell — gross margin has held in the 26.6%-27.9% band while operating margin expanded roughly 145 basis points sequentially, demonstrating that SG&A leverage (operating expenses of $901.8 million against $5.213 billion revenue) is amplifying the pricing recovery. Compared to typical metals distribution economics where gross margins of 25-30% and operating margins of 5-10% are the norm, Reliance is operating at the high end of its historical band, though the trailing twelve-month net margin of 5.17% and operating margin of 7.15% reflect the drag from the weaker prior quarters.
Balance sheet strength is a hallmark: debt-to-equity of just 0.278, a current ratio of 4.88, and interest coverage of roughly 30x (operating income of $552.1 million versus $18.4 million interest expense) indicate a conservatively financed, highly liquid operator. Free cash flow is the soft spot — TTM FCF of $491.9 million against a $15.18 billion market cap implies a thin FCF yield of roughly 3.2%, and quarterly FCF has been volatile ($133 million in Q3, $68.8 million in Q2, $87.2 million in Q1) as working capital absorbs cash during the revenue ramp (Q3 change in working capital of -$291.8 million, driven by a $265.3 million receivables build). ROE of 10.31% and ROA of 8.83% are respectable but below the company's cyclical peak levels, and the capital return program remains active with $44.7 million of buybacks and $63.8 million of dividends in Q3, funded comfortably by the balance sheet rather than external financing.
Quarterly Revenue
$5.2B
2026-09
Revenue YoY Growth
+42.8%
YoY Comparison
Gross Margin
27.9%
Latest Quarter
Free Cash Flow
$491900000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RS Overvalued?
Because Reliance is solidly profitable (Q3 2026 net income of $402.9 million), the PE ratio is the appropriate primary metric: the stock trades at a trailing PE of 20.53x versus a forward PE of 16.22x, a roughly 21% compression that implies the market expects meaningful earnings growth — consistent with consensus EPS estimates of $16.91 for the forward period versus the current run-rate. The forward multiple of 16.2x on estimated EPS of $16.91 is the more relevant anchor given the cyclical earnings inflection, and the gap between trailing and forward PE signals that investors are pricing in continued recovery rather than peak-cycle stagnation.
Against the broader Basic Materials/Steel sector, Reliance's 20.5x trailing PE and 1.06x PS ratio look reasonable rather than stretched — the PS ratio of 1.06x is notably low for a distributor with 27.9% gross margins, and the EV/EBITDA of 13.01x sits at a modest premium to typical steel distributor multiples of roughly 8-11x, justifiable given the company's superior balance sheet (0.28 debt-to-equity) and scale advantages. The PEG ratio of -1.98 is not meaningful due to negative or distorted growth-rate inputs and should be disregarded; the more telling comparison is the 2.12x price-to-book against a 10.3% ROE, which implies the market is paying roughly 2x book for a business earning low-double-digit returns — a fair-to-slightly-rich exchange that reflects the quality premium Reliance commands as the sector consolidator.
Historically, Reliance's PE has ranged widely with the cycle: from roughly 4.6x-6.7x in the 2022 boom (when earnings were peaking) to 32-34x in the 2024-2025 trough quarters, with the current 20.5x sitting in the middle of that band. The PS ratio of 1.06x, however, is near the low end of its multi-year range (historical PS readings clustered around 2.2x-5.2x in the 2021-2024 data), which is a function of the revenue surge rather than multiple compression — a classic cyclical signature where sales outrun the multiple. The market is thus pricing Reliance at a mid-cycle valuation on peak-ish earnings, suggesting limited multiple expansion upside but also limited downside if earnings hold, with the key risk being that forward EPS estimates of $16.91 prove optimistic if steel pricing rolls over.
PE
20.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~20x
vs. Industry Avg
21.1x
Industry PE ~21.1x*
EV/EBITDA
13.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on cash conversion and cyclical earnings quality. Despite $402.9 million of Q3 net income, TTM free cash flow is only $491.9 million, a roughly 3.2% FCF yield, because working capital absorbed $291.8 million in Q3 alone, including a $265.3 million receivables build — a pattern that repeats if revenue keeps ramping. Carbon steel at $3.119 billion of the $5.213 billion quarterly total concentrates roughly 60% of revenue in a single commodity whose pricing is set externally, and the trailing twelve-month net margin of 5.17% versus Q3's 7.73% shows how quickly profitability evaporates when the cycle turns. The forward EPS estimate of $16.91 assumes the current run-rate persists, so any pricing normalization would simultaneously compress earnings and the multiple applied to them.
Market and competitive risks are dominated by valuation and sentiment rather than balance sheet stress. At 20.53x trailing and 16.22x forward PE, Reliance trades at a modest premium to typical steel distributor EV/EBITDA multiples of 8-11x (it sits at 13.01x), a premium justified by scale but vulnerable to compression if growth stalls. The analyst configuration is a warning: 6 of 9 rate Hold, the mean rating is 2.67, and the entire $420-$446 target range sits only 0.7% to 7.0% above the $417.00 price, meaning there is no analyst cushion beneath the stock. With a beta of 0.953 the stock is slightly less volatile than the market, but its -19.37% max drawdown and the August 11% three-session air-pocket show that sector-specific shocks — steel price headlines, non-residential construction weakness, or a Nucor guidance reversal — can hit hard regardless of low beta. News flow is mixed: Nucor's upbeat Q3 pricing guidance supports the bull case, but Westlake's Cologne PVC closure highlights structural weakness in European commodity chemicals that could spill into industrial demand sentiment.
Worst-case scenario: steel pricing rolls over in Q4, forward EPS of $16.91 proves 20-30% too high, and the stock de-rates toward the low end of its historical cyclical band. A retest of the August swing low of $380.31 would cost about -8.8% from $417.00, and a full mean-reversion to the 52-week low of $263.12 would represent roughly -36.9%. Even the analyst low target of $420 offers no downside protection since it sits above the current price, so the realistic adverse path is a break below $380 support that opens the door to the $340-$360 zone, a -14% to -18% drawdown, with the -19.37% historical max drawdown as a reasonable proxy for a bad but not catastrophic outcome.
FAQ
The most severe risk is earnings quality: forward EPS of $16.91 assumes the Q3 run-rate persists, but the trailing twelve-month net margin of 5.17% versus Q3's 7.73% shows how fast profitability evaporates when the cycle turns, and a steel price rollover could make that estimate 20-30% too high. Second is revenue concentration — carbon steel at $3.119 billion is roughly 60% of the $5.213 billion quarterly total, so a single commodity price move hits both volume and margin simultaneously. Third is cash conversion: TTM free cash flow of $491.9 million is only a 3.2% yield, and Q3 working capital absorbed $291.8 million including a $265.3 million receivables build, which could strain the buyback and dividend if the revenue ramp continues. Fourth is valuation and sentiment risk: with the entire $420-$446 analyst range barely above the $417.00 price and 6 of 9 ratings at Hold, there is no analyst cushion, and the stock's -19.37% max drawdown plus the 11% three-session August air-pocket show sector shocks can hit hard despite a 0.953 beta.
The 12-month outlook splits into three scenarios. The base case (55% probability) targets $420-$446, assuming forward EPS of $16.91 is broadly achieved, gross margin stays in the 26.6%-27.9% band, and steel pricing holds roughly flat — leaving the stock range-bound near the $430.89 analyst average. The bear case (25%) targets $340-$380, driven by a Q4 steel price rollover, a forward EPS estimate 20-30% too high, and a break below the $380.31 August swing low toward the -19.37% historical max drawdown zone. The bull case (20%) targets $446-$465, requiring Q4 and Q1 results to confirm 10.59% operating margin as durable, steel pricing to extend into 2027, and analyst upgrades from the current 6-Hold consensus. The base case is most likely because the tight 6.2% analyst spread signals fair value is efficiently priced, with the key assumption being that Q3's margin is a new baseline rather than a cyclical peak.
RS looks fairly valued to modestly premium rather than cheap. The trailing PE of 20.53x compresses to 16.22x forward on consensus EPS of $16.91, implying the market already discounts roughly 21% earnings growth, while the PS ratio of 1.06x sits near the low end of its multi-year range — a classic cyclical signature where sales outrun the multiple. The EV/EBITDA of 13.01x is a modest premium to the roughly 8-11x typical for steel distributors, justified by the 0.278 debt-to-equity and scale advantages, and the 2.12x price-to-book against a 10.31% ROE is a fair-to-slightly-rich exchange for low-double-digit returns. Historically RS has traded anywhere from 4.6x-6.7x in the 2022 earnings boom to 32-34x in the 2024-2025 trough, so the current 20.5x sits mid-band. The market is effectively pricing a mid-cycle valuation on peak-ish earnings, implying limited multiple expansion upside but also limited downside if earnings hold — the key risk being that the $16.91 forward EPS proves optimistic.
From a risk/reward standpoint RS is balanced rather than compelling at $417.00: the average analyst target of $430.89 offers only +3.3% upside, and even the low target of $420.00 sits just above the current price, so there is essentially no analyst cushion beneath the stock. The reward case rests on forward EPS of $16.91 holding, which at 16.22x forward earnings would make the stock cheap if Q3's 10.59% operating margin proves a durable baseline rather than a cyclical peak. The downside case is concrete: a steel price rollover could take the stock to the $340-$360 zone (-14% to -18%) or, in a severe scenario, toward the $263.12 52-week low (-36.9%). With 6 of 9 analysts at Hold and a mean rating of 2.67, the professional consensus is that the recovery is already priced. It is a reasonable buy for patient investors seeking low-beta (0.953) cyclical materials exposure on a pullback toward the $380 support with margins intact, but not an attractive fresh-money entry at current levels.
RS is better suited to a medium-to-long holding period of at least 12-18 months than to short-term trading. It is a mid-to-late-stage cyclical whose earnings are levered to steel pricing, so timing the cycle matters more than quarterly momentum — the stock is down 1.62% over three months despite being up 5.24% in the past month, and the $428-$448 zone has repeatedly rejected price. The low beta of 0.953 and fortress balance sheet (0.278 debt-to-equity, 4.88 current ratio) make it a lower-volatility way to hold materials exposure, and the 1.68% dividend yield with a conservative 34.4% payout ratio provides modest income while waiting. However, the thin 3.2% free cash flow yield and working capital absorption mean cash returns are unlikely to accelerate near-term. A sensible approach is to build a position on pullbacks toward the $380 support with margins intact, and to reassess if Q4 gross margin falls below 26.6% or the stock breaks decisively below $380.